ArticleJournal for immunotherapy of cancer2021

Off-tumor IDO1 target engagements determine the cancer-immune set point and predict the immunotherapeutic efficacy.

Lin Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.